Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What CAGR Will the CRISPR Gene Editing Market Achieve During 2025–2034, and What Does It Indicate?
The market size for CRISPR gene editing has seen significant expansion in the past few years. Its growth is projected to continue, with an increase from $2.26 billion in 2024 to $2.88 billion in 2025, showing a compound annual growth rate (CAGR) of 27.4%. Numerous factors have contributed to the growth observed in the historic period, including enhanced demand for genome editing technologies, more government funding, a rise in cancer cases, increased chronic disease prevalence, heightened awareness of CRISPR technology, and an upgraded healthcare infrastructure.
There is a prediction of significant escalation in the CRISPR gene editing market over the next few years. It is projected to expand to a valuation of $7.51 billion by 2029 with an impressive compound annual growth rate (CAGR) of 27.1%. The expected advancement within this forecast period is influenced by the increased incidence of genetic disorders, heightened focus on precision medicine, escalating investment in CRISPR R&D, rising elderly population, and greater recognition of gene therapy procedures. The forecast period is set to witness trends such as advancements in gene editing technology, increase in number of research initiatives, drug discovery as well as development, enhancement in delivery methods, and the acceptance of CRISPR-edited agriculture.
What External and Internal Drivers Are Contributing to the Growth of the CRISPR Gene Editing Market’s Growth?
The escalating incidence rates of genetic abnormalities are likely to fuel the expansion of the CRISPR gene editing market in the future. Genetic anomalies, characterized as a health issue emerging from aberrations in the genome inclusive of change in either one gene (monogenic), multiple genes (polygenic), or chromosomal irregularities, is on the rise due to factors like genetic mutations, an ageing population, and marriages between close relatives. CRISPR gene editing greatly contributes to managing such genetic issues by rendering precise and target-oriented modifications in the DNA. Moreover, scientists utilize CRISPR to identify and rectify specific mutations responsible for genetic abnormalities, reinstating regular function, and mitigating symptoms of diseases such as cystic fibrosis and sickle cell anemia. For instance, as per the Cystic Fibrosis (CF) Foundation, a non-profit based in the US, in July 2022, an increase in the number of patients suffering from cystic fibrosis was recorded. In 2022, nearly 40,000 children and adults in the United States and more than 105,000 individuals worldwide were diagnosed with cystic fibrosis. Thus, the growing occurrence of genetic disorders is promoting the surge of the CRISPR gene editing market.
Explore Comprehensive Insights Into The Global CRISPR Gene Editing Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15549&type=smp
Who Are the Key Firms Paving the Way for Growth in the CRISPR Gene Editing Market?
Major companies operating in the CRISPR gene editing market are:
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Agilent Technologies Inc.
• GenScript
• Integrated DNA Technologies Inc.
What Are the Most Influential Trends Currently Shaping the CRISPR Gene Editing Market?
In a bid to broaden their customer reach, boost sales, and expand revenues, prominent players in the CRISPR gene editing arena are placing a keen emphasis on introducing innovative merchandise, predominantly gene therapy. Gene therapy employs genes as a solution to combat, preclude, or heal diseases and maladies. In an exemplification of this in December 2023, Casgevy, a cell-oriented gene therapy, was given the green light by the US Food and Drug Administration (FDA) for the management of sickle cell disease. This therapy uses CRISPR/Cas9, a form of genome editing machinery, to modify hematopoietic stem cells.
Secure Your Global CRISPR Gene Editing Market Report Now for Fast and Efficient Delivery!
https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report
What Are the Major Segments of the CRISPR Gene Editing Market and Their Role in Driving Growth?
The CRISPR gene editing market covered in this report is segmented –
1) By Type: CRISPR-Associated Nuclease (Cas Nuclease), Guide Ribonucleic Acid (RNA), Deoxyribonucleic Acid (DNA) Ligase, Restriction Endonuclease, Other Types
2) By Services: Design Tools, Plasmid And Vector, CRISPR-Associated Protein 9 (Cas9) And Guide Ribonucleic Acid (g-RNA), Delivery System Products, Other Services
3) By Technology: CRISPR Or Cas9, Zinc Finger Nucleases, Other Technologies
4) By Application: Agricultural, Biomedical, Industrial, Genome Engineering, Disease Models, Functional Genomics, Other Applications
5) By End User: Academic Institutes And Research Centers, Biotechnology Companies, Contract Research Organizations (CROs), Pharmaceutical And Biopharmaceutical Companies
Subsegments:
1) By CRISPR-Associated Nuclease (Cas Nuclease): Cas9, Cas12, Cas13, Other Cas Nucleases
2) By Guide Ribonucleic Acid (RNA): Single-guide RNA (sgRNA), Dual-guide RNA, Synthetic Guide RNA
3) By Deoxyribonucleic Acid (DNA) Ligase: T4 DNA Ligase, E. coli DNA Ligase, Other DNA Ligases
4) By Restriction Endonuclease: Type II Restriction Enzymes, Type I And III Restriction Enzymes, Other Restriction Enzymes
5) By Other Types: CRISPR Delivery Systems, CRISPR Plasmids, CRISPR-Based Diagnostic Tools
Which Regions Are Essential for the Growth of the CRISPR Gene Editing Market?
North America was the largest region in the CRISPR gene editing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Definition of the CRISPR Gene Editing Market Impacting Future Growth?
Clustered regularly interspaced short palindromic repeats (CRISPR) gene editing is a revolutionary biotechnology tool that enables precise modifications to the DNA of living organisms. This technology utilizes a natural defense mechanism found in bacteria, where sequences of DNA, known as CRISPR, are used to identify and cut specific genetic sequences. CRISPR gene editing allows for the addition, removal, or alteration of genetic material, making it a powerful technique for research, therapeutic applications, and potential treatments for genetic disorders.
Browse Through More Similar Reports By The Business Research Company:
Cell and Gene Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report
Gene Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report
Plant Breeding And CRISPR Plants Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
